June 26, 2009
Santhera Enters Agreement with Columbia University to Investigate Additional Potential of Catena® in MELAS -- more

June 24, 2009
Santhera and NIH Collaborate To Evaluate Catena® in Primary Progressive Multiple Sclerosis -- more

June 22, 2009
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration -- more

June 1, 2009
Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) -- more

May 29, 2009
AV-951 Demonstrates Prolonged Progression-Free Survival and Excellent Safety Profile in Patients with Advanced Kidney Cancer -- more

May 27, 2009
ExonHit and Institut Gustave Roussy Announce the Signing of a License Agreement for Novel Breast Cancer Diagnostic Assay -- more

May 21, 2009
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF -- more

May 20, 2009
Ceres Yield Results: Energy Crop Benefits are Greatly Underestimated -- more

May 19, 2009
Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company; Completes $12M Equity Financing -- more

May 10, 2009
ZettaCore Raises $21M; Panasonic Makes Strategic Investment -- more




May 6, 2009
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round -- more

May 5, 2009
Forbes Magazine - VaxInnate: The Flu Vaccine Accelerator -- more

April 30, 2009
Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board -- more

April 30, 2009
Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory -- more

April 27, 2009
VaxInnate’s Seasonal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Study -- more

April 23, 2009
Asterand Announces Collaborative Agreement to Characterise Antibodies -- more

April 14, 2009
Astex Presents Key Data Differentiating its Phase I HSP90 inhibitor, AT13387, at the AACR Annual Meeting 2009 -- more

April 14, 2009
Astex Reports Positive Clinical Biomarker Data from its Phase I study on CDK Inhibitor AT7519 at the AACR Annual Meeting 2009 -- more

April 13, 2009
High-Yielding Switchgrass the Focus of Ceres and University of Georgia Researchers -- more

April 8, 2009
Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation -- more

April 2, 2009
Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 -- more

March 31, 2009
Astex Achieves Milestones in Drug Discovery Collaboration -- more

March 30, 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer -- more

March 30, 2009
CircuLite Demonstrates Long-Term Improvements and Hemodynamic Benefits with Synergy® Partial Circulatory Support in Chronic Heart Failure Patients -- more


Archived News Items